EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 8.93 BATS BZX Real-Time Price As of 10:16am ET |  -0.13 / -1.43%Today’s Change | 7.30 Today|||52-Week Range 21.50 | -27.04% Year-to-Date |
Latest EYPT News | Press Releases
No recent news for EyePoint Pharmaceuticals Inc.
Today’s Trading
| Previous close | 9.06 |
| Today’s open | 9.17 |
| Day’s range | 8.92 - 9.19 |
| Volume | 2,467 |
| Average volume (3 months) | 617,571 |
| Market cap | $286.0M |
Data as of 10:16am ET, 01/25/2022
Growth & Valuation
| Earnings growth (last year) | +35.05% |
| Earnings growth (this year) | -2,029.41% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +69.10% |
| P/E ratio | NM |
| Price/Sales | 2.45 |
| Price/Book | 8.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLLSCellectis SA | -0.21 | -3.18% |
| MEIPMEI Pharma Inc | -0.01 | -0.44% |
| EOLSEvolus Inc | -0.07 | -1.28% |
| IPHAInnate Pharma SA | +0.13 | +3.54% |
Data as of 10:19am ET, 01/25/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $34.4M |
| Annual profit (last year) | -$45.4M |
| Net profit margin | -131.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
